Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Idenix Drops After FDA Puts Hold on Another Hepatitis Drug
Minyanville
Monday, August 27, 2012 - 10:40am
tags:
hepatitis C, Idenix, FDA, Bristol-Myers Squibb, IDX19368, IDX184
Merck To Supreme Court: Review ‘Pay To Delay’
Pharmalot
Monday, August 27, 2012 - 10:34am
tags:
Merck, Supreme Court, pay-for-delay
Roche Drug ‘Significantly’ Extended Lives In Cancer Trial
Bloomberg
Monday, August 27, 2012 - 10:34am
tags:
Roche, T-DM1, breast cancer
Teva $1 Billion Market Depends On New Test Of Laquinimod
Bloomberg
Monday, August 27, 2012 - 10:33am
tags:
Teva Pharmaceuticals, laquinimod, MS, multiple sclerosis
Upcoming Catalysts For Exelixis And Immunogen
Seeking Alpha
Monday, August 27, 2012 - 10:32am
tags:
Exelixis, Immunogen, prostate cancer, breast cancer
2 Positive News Items Help The Cadence Pharmaceuticals Investment Thesis
Seeking Alpha
Monday, August 27, 2012 - 10:30am
tags:
Cadence Pharmaceuticals
Sanofi Receives FDA Refusal To File for Lemtrada, Pushes Back Launch Potential
Yahoo/Reuters
Monday, August 27, 2012 - 10:24am
tags:
Sanofi, FDA, Lemtrada, Genzyme
AstraZeneca In Strong Position With Brilinta
Seeking Alpha
Monday, August 27, 2012 - 10:21am
tags:
Brilinta, AstraZeneca, Bristol-Myers Squibb, GSK, Sanofi, Human Genome Sciences, Medicines Company
Bayer’s Xarelto Helped Survival After Heart Attack: Study
Bloomberg
Monday, August 27, 2012 - 10:20am
tags:
Bayer, Xarelto, heart attacks, bloodthinners, JNJ
Lilly’s Alzheimer Drug Finding Splits Investors, Doctors
Bloomberg
Monday, August 27, 2012 - 10:15am
tags:
physicians, investors, Alzheimer's disease, Eli Lilly, solanezumab
Merck Provides Update on Cardiovascular Development Programs
Yahoo/BusinessWire
Sunday, August 26, 2012 - 11:58am
tags:
Merck, Vorapaxar, MK524A, Tredaptive
The Dividend Investors' Guide: Part XXV - America's (Continued) Addiction To Drug Companies
Seeking Alpha
Sunday, August 26, 2012 - 11:56am
tags:
Novartis, Abbott Labs, Sanofi, Bristol-Myers Squibb, Medicis
The Week in Review: Joincare To Invest $157 Million For Antibiotic Facility
Seeking Alpha
Sunday, August 26, 2012 - 11:32am
tags:
Joincare Pharmaceutical Group, Fina Biosolutions, Golden Meditech Holdings, Thermogenesis, AXP AutoXpress, stem cells, Hangzhou Tigermed Consulting, FortuneRock, Biostar Pharmaceuticals
New Novartis drug shows potential in heart failure treatment
Reuters
Sunday, August 26, 2012 - 11:28am
tags:
Novartis, LCZ696, heart failure
Lilly heart drug Effient fails to carve new niche
Reuters
Sunday, August 26, 2012 - 11:04am
tags:
Eli Lilly, Effient, Plavix, Daiichi Sankyo, Sanofi, antiplatelet therapy, Bristol-Myers Squibb
TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients
Forbes
Sunday, August 26, 2012 - 11:01am
tags:
Sanofi, Prasugrel, Plavix, Effient, Daiichi Sankyo, Clopidogrel, antiplatelet therapy, Eli Lilly
A $3 Biotech Play With Recent Positive Catalysts
Seeking Alpha
Sunday, August 26, 2012 - 10:57am
tags:
Discovery Labs
Arena Is Poised To Move
Seeking Alpha
Saturday, August 25, 2012 - 12:59pm
tags:
Arena Pharmaceuticals
Teva launches anti-depression drug in US
Equities.com
Saturday, August 25, 2012 - 12:58pm
tags:
Symbyax, generics, antidepressants, Eli Lilly
US FDA approves Watson Pharma's lidocaine topical patch 5%
Pharmabiz
Saturday, August 25, 2012 - 12:54pm
tags:
Watson Pharmaceuticals, lidocaine, generics, Endo, lidoderm, pain management

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.